Reckitt Benckiser Group Stock Price To Sales
| RBGPF Stock | USD 59.69 0.04 0.07% |
Reckitt Benckiser Group fundamentals help investors to digest information that contributes to Reckitt Benckiser's financial success or failures. It also enables traders to predict the movement of Reckitt Pink Sheet. The fundamental analysis module provides a way to measure Reckitt Benckiser's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Reckitt Benckiser pink sheet.
Reckitt |
Reckitt Benckiser Group Company Price To Sales Analysis
Reckitt Benckiser's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Reckitt Benckiser Price To Sales | 3.75 X |
Most of Reckitt Benckiser's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Reckitt Benckiser Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Reckitt Benckiser Group has a Price To Sales of 3.7497 times. This is 54.31% higher than that of the Consumer Defensive sector and 81.14% higher than that of the Household & Personal Products industry. The price to sales for all United States stocks is 67.17% higher than that of the company.
Reckitt Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Reckitt Benckiser's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Reckitt Benckiser could also be used in its relative valuation, which is a method of valuing Reckitt Benckiser by comparing valuation metrics of similar companies.Reckitt Benckiser is currently under evaluation in price to sales category among its peers.
Reckitt Fundamentals
| Return On Equity | 0.39 | |||
| Return On Asset | 0.0681 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 61.62 B | |||
| Shares Outstanding | 715.77 M | |||
| Shares Owned By Insiders | 0.09 % | |||
| Shares Owned By Institutions | 60.03 % | |||
| Price To Earning | 30.53 X | |||
| Price To Book | 4.62 X | |||
| Price To Sales | 3.75 X | |||
| Revenue | 13.23 B | |||
| Gross Profit | 7.69 B | |||
| EBITDA | 465 M | |||
| Net Income | (32 M) | |||
| Cash And Equivalents | 1.29 B | |||
| Cash Per Share | 1.80 X | |||
| Total Debt | 6.81 B | |||
| Debt To Equity | 1.10 % | |||
| Current Ratio | 0.70 X | |||
| Book Value Per Share | 12.47 X | |||
| Cash Flow From Operations | 1.7 B | |||
| Earnings Per Share | 5.15 X | |||
| Price To Earnings To Growth | 3.26 X | |||
| Target Price | 7400.0 | |||
| Number Of Employees | 40 K | |||
| Beta | 0.17 | |||
| Market Capitalization | 49.74 B | |||
| Total Asset | 26.95 B | |||
| Retained Earnings | 21.09 B | |||
| Working Capital | (2.59 B) | |||
| Current Asset | 3.48 B | |||
| Current Liabilities | 6.07 B | |||
| Z Score | 4.2 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 2.57 % | |||
| Net Asset | 26.95 B | |||
| Last Dividend Paid | 1.75 |
About Reckitt Benckiser Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Reckitt Benckiser Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reckitt Benckiser using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reckitt Benckiser Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Reckitt Pink Sheet
Reckitt Benckiser financial ratios help investors to determine whether Reckitt Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Reckitt with respect to the benefits of owning Reckitt Benckiser security.